Meet The Top Attys In AbbVie's Antitrust Battle Royal

By Jeff Overley · June 7, 2019, 8:00 PM EDT

Powerhouse plaintiffs lawyers and BigLaw brawlers are set for a rowdy antitrust battle over AbbVie's alleged scheme to protect the market for its immunosuppressant Humira, the world's best-selling drug, by cultivating an impenetrable...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Related Sections

Case Information

Case Title

In Re: Humira (Adalimumab) Antitrust Litigation

Case Number

1:19-cv-01873

Court

Illinois Northern

Nature of Suit

410(Anti-Trust)

Date Filed

March 18, 2019